Sangamo Therapeutics, Inc. (SGMO)
0.4837
-0.02
(-3.89%)
USD |
NASDAQ |
Dec 10, 16:00
0.485
0.00 (0.00%)
After-Hours: 18:11
Sangamo Therapeutics Profit Margin (Quarterly): -6.01K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novavax, Inc. | -287.3% |
| Arcturus Therapeutics Holdings, Inc. | -95.02% |
| Pfizer Inc. | 21.32% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -587.7% |
| Return on Assets | -111.4% |
| Return on Invested Capital | -242.3% |
| Gross Profit Margin (Quarterly) | -226.7% |
| Operating Margin (Quarterly) | -6.21K% |
| Return on Net Operating Assets | -308.0% |